NTRA-2112

· Elgan Pharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NTRA-2112, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants [Phase 3]